Mechanisms of thrombogenesis associated with diabetes mellitus: what defines the prognosis of invasive myocardial revascularization methods?
Cardiovascular intervention for myocardial revascularization dominates modern treatment of ischaemic heart disease (IHD). Current efficiency and safety of this method could never be achieved without the development of antiplatelet agents that provide indispensable protection for endovascular interve...
Main Authors: | Irina Ziyatovna Bondarenko, Irina Alexandrovna Shirshina |
---|---|
Formato: | Artigo |
Idioma: | English |
Publicado: |
Endocrinology Research Centre
2013-09-01
|
Series: | Сахарный диабет |
Subjects: | |
Acceso en liña: | https://www.dia-endojournals.ru/jour/article/view/95 |
Títulos similares
-
Arterial hypertension and coronary heart disease: the place of angiotensin II receptor antagonists
por: E. O. Taratukhin
Publicado: (2012-12-01) -
LYMPHOCYTE-TO PLATELET ADHERENCE IN PATIENTS WITH ERYSIPELAS
por: A. N. Emelyanova, et al.
Publicado: (2014-07-01) -
Antihyperglycemic therapy in patients with type 2 diabetes mellitus and ischaemic heart disease: management during acute period of myocardial infarction and interventional procedures
por: Olga Mikhailovna Smirnova, et al.
Publicado: (2012-09-01) -
Metabolomic, transcriptomic and genetic integrative analysis reveals important roles of adenosine diphosphate in haemostasis and platelet activation in non‐small‐cell lung cancer
por: Long T. Hoang, et al.
Publicado: (2019-11-01) -
DISORDERS OF PLASMA AND PLATELET PATHWAYS OF HEMOSTASIS IN PATIENTS WITH ARTERIAL HYPERTENSION COMBINED WITH DISLIPOPROTEINEMIA
por: M. Y. Zhuk, et al.
Publicado: (2003-10-01)